Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

A new, better Ozempic? Scientists from the University of Copenhagen say they have developed a drug that decreases appetite ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

Pemvidutide is a promising GLP-1/glucagon dual receptor agonist that focuses on fundamental metabolic processes to stimulate ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...